Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

NINDS Neuroscience Funding Announcements



Development of PET and SPECT Ligands for Brain Imaging (SBIR)

Funding Contact(s): Daofen Chen, Ph.D.
Funding Categories: Small Business, Systems and Cognitive Neuroscience

Brief Description:

This initiative is intended to stimulate the commercial development of novel radioligands for positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging in human brain, and to incorporate pilot or clinical feasibility evaluation in pre-clinical studies, model development, or clinical studies. The NIH institutes listed in this FOA are specifically interested in the development of radioligands for molecular targets (e.g., receptors, cell adhesion molecules, intracellular messengers, and disease related proteins) that are of broad interest to the scientific community. These radiotracers will be used for neuroimaging as well as potential biological markers and surrogate endpoints for translational and clinical research, drug discovery and development, and clinical trials. Also appropriate for this FOA are applications proposing research and development of new technologies for radiotracer development.



Grant Mechanism: R43/R44
NIH Guide: PA-06-017
Release Date: 2005-10-17
Expiration Date: 2008-05-08

Grant Mechanism: R43/R44
NIH Guide: PA-06-018
Expiration Date: 2008-05-08